Table 1. Demographic and presentation characteristics of 89 studied patients.
OMP group (no.= 44) | PAN group (no.=41) | |
Gender (male/Female) | 33/11 | 30/11 |
Age (years) (mean ±SD) | 57.25±16.45 | 61.66±17.17 |
NSAID, ASA use (%) | 19 (43) | 17 (41) |
Ulcer Location | ||
Gastric (%) | 24 (54) | 18 (44) |
Duodenal (%) | 17 (39 ) | 20 (49) |
Both (%) | 3 (7 ) | 3 (7) |
Ulcer stigmata | ||
Adherent clot (%) | 5 (11) | 3 (7) |
Visible Vessel (%) | 25 (57) | 26 (63) |
Blood oozing (%) | 8 (18) | 5 (13) |
Active Bleeding (%) | 6 (14) | 7 (17) |
Therapeutic intervention | ||
Epinephrine injection alone (%) | 29 (66) | 28 (68) |
Epinephrine + APC (%) | 14 (32) | 12 (29.5) |
Epinephrine + endoclips (%) | 1 (2) | 1 (2.5) |